Cargando…

Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders

Patient Activation Measure-13 (PAM-13) is a valid and widely used questionnaire that assess an individual’s knowledge, confidence, and skills for self-management of their chronic illness. Although there is some evidence regarding its reliability, the test–retest reliability has not been investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Melby, Katrine, Nygård, Mona, Brobakken, Mathias Forsberg, Gråwe, Rolf W., Güzey, Ismail Cüneyt, Reitan, Solveig Klæbo, Vedul-Kjelsås, Einar, Heggelund, Jørn, Tchounwou, Paul B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908201/
https://www.ncbi.nlm.nih.gov/pubmed/33572717
http://dx.doi.org/10.3390/ijerph18031185
_version_ 1783655658072047616
author Melby, Katrine
Nygård, Mona
Brobakken, Mathias Forsberg
Gråwe, Rolf W.
Güzey, Ismail Cüneyt
Reitan, Solveig Klæbo
Vedul-Kjelsås, Einar
Heggelund, Jørn
Tchounwou, Paul B.
author_facet Melby, Katrine
Nygård, Mona
Brobakken, Mathias Forsberg
Gråwe, Rolf W.
Güzey, Ismail Cüneyt
Reitan, Solveig Klæbo
Vedul-Kjelsås, Einar
Heggelund, Jørn
Tchounwou, Paul B.
author_sort Melby, Katrine
collection PubMed
description Patient Activation Measure-13 (PAM-13) is a valid and widely used questionnaire that assess an individual’s knowledge, confidence, and skills for self-management of their chronic illness. Although there is some evidence regarding its reliability, the test–retest reliability has not been investigated among patients with substance use disorders (SUDs) or schizophrenia spectrum disorders. We investigated the internal consistency and test–retest reliability of PAM-13 in these populations. Test–retest reliability was analysed using data from 29 patients with SUDs and 28 with schizophrenia spectrum disorders. Cronbach’s α and Intraclass Correlation Coefficient (ICC) scores were used to examine internal consistency and test–retest reliability, respectively. Of the 60 collected test–retest questionnaires, 57 were included in the analyses. No mean differences between time one (T1) and time two (T2) were observed in either patient group, except for item 12 in schizophrenia spectrum disorders patients (p < 0.05). Internal consistency for T1 and T2 was 0.75 and 0.84 in SUDs patients and 0.87 and 0.81 in schizophrenia spectrum disorders patients, respectively. The ICC was r = 0.86 in patients with SUDs and r = 0.93 in patients with schizophrenia spectrum disorders. To conclude, PAM-13 showed good internal consistency and test–retest reliability in SUDs and schizophrenia spectrum disorders patients.
format Online
Article
Text
id pubmed-7908201
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79082012021-02-27 Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders Melby, Katrine Nygård, Mona Brobakken, Mathias Forsberg Gråwe, Rolf W. Güzey, Ismail Cüneyt Reitan, Solveig Klæbo Vedul-Kjelsås, Einar Heggelund, Jørn Tchounwou, Paul B. Int J Environ Res Public Health Brief Report Patient Activation Measure-13 (PAM-13) is a valid and widely used questionnaire that assess an individual’s knowledge, confidence, and skills for self-management of their chronic illness. Although there is some evidence regarding its reliability, the test–retest reliability has not been investigated among patients with substance use disorders (SUDs) or schizophrenia spectrum disorders. We investigated the internal consistency and test–retest reliability of PAM-13 in these populations. Test–retest reliability was analysed using data from 29 patients with SUDs and 28 with schizophrenia spectrum disorders. Cronbach’s α and Intraclass Correlation Coefficient (ICC) scores were used to examine internal consistency and test–retest reliability, respectively. Of the 60 collected test–retest questionnaires, 57 were included in the analyses. No mean differences between time one (T1) and time two (T2) were observed in either patient group, except for item 12 in schizophrenia spectrum disorders patients (p < 0.05). Internal consistency for T1 and T2 was 0.75 and 0.84 in SUDs patients and 0.87 and 0.81 in schizophrenia spectrum disorders patients, respectively. The ICC was r = 0.86 in patients with SUDs and r = 0.93 in patients with schizophrenia spectrum disorders. To conclude, PAM-13 showed good internal consistency and test–retest reliability in SUDs and schizophrenia spectrum disorders patients. MDPI 2021-01-29 2021-02 /pmc/articles/PMC7908201/ /pubmed/33572717 http://dx.doi.org/10.3390/ijerph18031185 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Melby, Katrine
Nygård, Mona
Brobakken, Mathias Forsberg
Gråwe, Rolf W.
Güzey, Ismail Cüneyt
Reitan, Solveig Klæbo
Vedul-Kjelsås, Einar
Heggelund, Jørn
Tchounwou, Paul B.
Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders
title Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders
title_full Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders
title_fullStr Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders
title_full_unstemmed Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders
title_short Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders
title_sort test-retest reliability of the patient activation measure-13 in adults with substance use disorders and schizophrenia spectrum disorders
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908201/
https://www.ncbi.nlm.nih.gov/pubmed/33572717
http://dx.doi.org/10.3390/ijerph18031185
work_keys_str_mv AT melbykatrine testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders
AT nygardmona testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders
AT brobakkenmathiasforsberg testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders
AT grawerolfw testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders
AT guzeyismailcuneyt testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders
AT reitansolveigklæbo testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders
AT vedulkjelsaseinar testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders
AT heggelundjørn testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders
AT tchounwoupaulb testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders